These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31652589)

  • 1. Chemometrics Approaches in Forced Degradation Studies of Pharmaceutical Drugs.
    Roberto de Alvarenga Junior B; Lajarim Carneiro R
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
    Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new impurities of enalapril maleate on oxidation in the presence of magnesium monoperoxyphthalate.
    Toporisic R; Mlakar A; Hvala J; Prislan I; Zupancic-Kralj L
    J Pharm Biomed Anal; 2010 Jun; 52(2):294-9. PubMed ID: 20122808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical interactions between an active pharmaceutical ingredient and its counterion in a tromethamine salt under forced degradation conditions.
    Loeser E; Sutton P; Skorodinsky A; Lin M; Yowell G
    Drug Dev Ind Pharm; 2012 Mar; 38(3):357-64. PubMed ID: 22088139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability-indicating UHPLC method for determination of nevirapine in its bulk form and tablets: identification of impurities and degradation kinetic study.
    Reis NF; de Assis JC; Fialho SL; Pianetti GA; Fernandes C
    J Pharm Biomed Anal; 2016 Jul; 126():103-8. PubMed ID: 27179642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
    Bao Y; Mo X; Xu X; He Y; Xu X; An H
    J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination.
    Peterka TR; Lušin TT; Bergles J; Ham Z; Grahek R; Urleb U
    Acta Pharm; 2019 Sep; 69(3):363-380. PubMed ID: 31259735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemometric study of the excipients' influence on polymorphic-behavior. Mefenamic acid as case of study.
    Antonio M; Calvo NL; Maggio RM
    J Pharm Biomed Anal; 2019 Jun; 170():8-15. PubMed ID: 30901720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.
    Wu Y; Levons J; Narang AS; Raghavan K; Rao VM
    AAPS PharmSciTech; 2011 Dec; 12(4):1248-63. PubMed ID: 21948318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
    Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
    J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excipient-related impurities in liposome drug products.
    Wang C; Gamage PL; Jiang W; Mudalige T
    Int J Pharm; 2024 May; 657():124164. PubMed ID: 38688429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
    Hasanain F; Guenther K; Mullett WM; Craven E
    PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.
    Maggio RM; Calvo NL; Vignaduzzo SE; Kaufman TS
    J Pharm Biomed Anal; 2014 Dec; 101():102-22. PubMed ID: 24853620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
    J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progresses in Analytical Perspectives of Degradation Studies and Impurity Profiling in Pharmaceutical Developments: An Updated Review.
    Jahani M; Fazly Bazzaz BS; Akaberi M; Rajabi O; Hadizadeh F
    Crit Rev Anal Chem; 2023; 53(5):1094-1115. PubMed ID: 35108132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of chemical stability of sitagliptin by LC-UV, LC-MS and FT-IR methods.
    Gumieniczek A; Berecka A; Mroczek T; Wojtanowski K; Dąbrowska K; Stępień K
    J Pharm Biomed Anal; 2019 Feb; 164():789-807. PubMed ID: 30503802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced degradation of nepafenac: Development and validation of stability indicating UHPLC method.
    Runje M; Babić S; Meštrović E; Nekola I; Dujmić-Vučinić Ž; Vojčić N
    J Pharm Biomed Anal; 2016 May; 123():42-52. PubMed ID: 26871279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.